1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Lebanon Pharmaceuticals and Healthcare Report Q4 2016

Lebanon Pharmaceuticals and Healthcare Report Q4 2016

  • September 2016
  • -
  • Business Monitor International
  • -
  • 78 pages

Includes 3 FREE quarterly updates


BMI View: Growth in Lebanon's pharmaceutical market will be heavily driven by the sales of high-value prescription medicines thanks to an aging population, relatively high per capita spending and rising disease burden. Furthermore, the Health Ministry's recent move to increase healthcare coverage for citizens over the age of 64 highlights the country's commitment to improving healthcare quality and access across the country. However, ongoing regional instability and Lebanon's own economic stagnation will continue to dampen multinational drugmakers' interest in the market.

Headline Expenditure Projections
- Pharmaceuticals: LBP2.47trn (USD1.64bn) in 2015 to LBP2.60trn (USD1.72bn) in 2016; +5.5% in local currency and US dollar terms. Forecast revised downwards slightly from last quarter.
- Healthcare: LBP5.04trn (USD3.34bn) in 2015 to LBP5.27trn (USD3.50bn) in 2016; +4.8% in local currency and US dollar terms. Forecast unchanged from last quarter.

Table Of Contents

Lebanon Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Lebanon 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Lebanon 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Lebanon 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Lebanon 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Lebanon 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Lebanon 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Lebanon 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Lebanon 2012-2020) 24
OTC Medicine Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Lebanon 2012-2020) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Lebanon 2014-2020) 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Lebanon 2014-2020) 30
Industry Risk/Reward Index 31
Middle East and Africa Risk/Reward Index - Q4 2016 31
Lebanon Risk/Reward Index 39
Rewards 39
Risks 39
Regulatory Review 41
Regulatory Developments 41
Counterfeit Drugs 43
Public Sector Procurement 43
Intellectual Property Issues 44
Free Trade Agreements 45
Pricing Regime 46
Reimbursement Regime 48
Market Overview 49
Healthcare Sector 50
Medical Tourism 53
Regional Healthcare Collaboration 54
Clinical Trials 55
Epidemiology 56
Competitive Landscape 58
Research-Based Industry 58
Table: Multinational Market Activity 59
Generic Drugmakers 59
Pharmaceutical Distribution 60
Pharmacy Retail Sector 61
Company Profile 62
Algorithm 62
Pharmaline 64
Demographic Forecast 67
Table: Population Headline Indicators (Lebanon 1990-2025) 68
Table: Key Population Ratios (Lebanon 1990-2025) 68
Table: Urban/Rural Population and Life Expectancy (Lebanon 1990-2025) 69
Table: Population By Age Group (Lebanon 1990-2025) 69
Table: Population By Age Group % (Lebanon 1990-2025) 70
Glossary 72
Methodology 74
Pharmaceutical Expenditure Forecast Model 74
Healthcare Expenditure Forecast Model 74
Notes On Methodology 75
Risk/Reward Index Methodology 76
Index Overview 77
Table: Pharmaceutical Risk/Reward Index Indicators 77
Indicator Weightings 78

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.